News » Archives » September 2018

Study uncovers new hurdle for developing immunotherapies

Author: Deanna Csomo McCool

The body’s immune system is a valiant weapon against disease, and harnessing its power through a technique called immunotherapy is at the forefront of current research to treat cancer and other diseases. That’s why an unexpected finding by Notre Dame researchers and their collaborators, related to the way two distinctively different peptide antigens react with one T-cell receptor, tosses a new wrench into the process of building better molecules to develop immunotherapies.

Read More

University of Notre Dame to host Indiana CTSI retreat

Author: Brandi Klingerman


Indiana University, Purdue University, and the University of Notre Dame invite all researchers to attend the Indiana Clinical and Translational Sciences Institute (CTSI) retreat. The event will take place at the University of Notre Dame’s McCourtney Hall on Friday, October 26, 2018 from 9:00 a.m. to 4:15 p.m.

Read More

Biophysicist awarded $1.1 million NIH grant to study role of protein dynamics in antibiotic resistance

Author: Cheryl Schairer

Jeff W. Peng

The β-lactams are a vast family of antibiotics that include the well-known penicillins; they remain the most widely administered antibiotics around the globe.  Results from the research of Jeff W. Peng, associate professor of chemistry and biochemistry, could reveal new strategies for coping with the expanding scope of β-lactam resistance now happening among Gram-negative pathogens.

Read More